InVivo Therapeutics Holdings Corp

04IC - F
Overview
Dividend safety
Dividends
Fundamentals
Add to watchlist

Add to calculator

Compare stock
InVivo Therapeutics Holdings Corp
04IC
-
F
Overview
Dividend safety
Dividends
Fundamentals

Overview

Create a free account to get access to stock details and our dividend tracker

We won't send you any spam and we don't want a credit card.

About stock

Health care
Sector
Biotechnology
Industry

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.

Address: One Kendall Square, Cambridge, MA, United States, 02139

Similar stocks

Based on sector and market capitalization

Report issue